c-Jun is over-expressed in AML patients and contributes to a block in granulocyte differentiation and development of AML (Pulikkan et al, 2010; Rangatia et al, 2003), thus implicating an important role of AP-1 activation by PRL-3 in tumour development. The gene discussed is FOS; the disease is neoplasm.